Covered recipient · General Payments record
RYAN MORGAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$124,469.64
- Reported across 185 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $38,828.00 | 13 |
| Honoraria | $1,553.00 | 2 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,422.34 | 2 |
| Food and Beverage | $1,132.61 | 34 |
| Travel and Lodging | $735.65 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kedplasma LLC | $38,400.00 | 12 |
| Madrigal Pharmaceuticals | $2,054.21 | 7 |
| Rhythm Pharmaceuticals, Inc. | $1,991.94 | 4 |
| Amgen Inc. | $186.34 | 5 |
| Novo Nordisk AS | $183.88 | 5 |
| DEXCOM, INC. | $152.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $150.00 | 2 |
| Medicure Pharma Inc. | $122.34 | 1 |
| Regeneron Healthcare Solutions, Inc. | $114.59 | 1 |
| Lilly USA, LLC | $97.62 | 5 |
| Corcept Therapeutics | $43.22 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $41.88 | 2 |
| ABBVIE INC. | $38.71 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $38.44 | 2 |
| PFIZER INC. | $15.50 | 1 |
| Esperion Therapeutics, Inc. | $13.51 | 1 |
| Astellas Pharma US Inc | $13.42 | 1 |
| Currax Pharmaceuticals LLC | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.